Zobrazeno 1 - 10
of 11
pro vyhledávání: '"39"'
Publikováno v:
Journal of Pediatric Hematology/Oncology. 42:e299-e304
Background The prognostic role of copy number variation is upcoming in Wilms tumor, and its identification will help in tailored therapy for improved cure. Study design This was a retrospective, nested case-control, pilot study. Materials and methods
Autor:
Roelie M. Wösten-van Asperen, Martine van Grotel, Josephus P. J. van Gestel, Joppe Nijman, Mila van Dorst, Birgitta Versluijs, Marry M. van den Heuvel-Eibrink
Publikováno v:
Journal of Pediatric Hematology/Oncology. 42:e1-e6
The use of high-flow nasal cannula (HFNC) oxygen therapy is growing as an alternative to standard oxygen. However, its use in patients treated for malignancies, including hematopoietic stem cell transplantation (HSCT) patients, is controversial. In t
Autor:
David Josey, Hafsat Mashegu, Gaylen D. Patterson, Frederick E. Barr, Melissa N. McNaull, Cynthia W. Karlson, Samantha R. Seals, Jordan Rutherford, Clinton Carroll, Suvankar Majumdar, Warren L. May
Publikováno v:
J Pediatr Hematol Oncol
Acute chest syndrome (ACS) is a common and serious lung complication in sickle cell disease. A retrospective medical chart review was performed over a 6-year period in all pediatric ACS patients to investigate whether factors during the initial hospi
Autor:
Daniel Orbach, Marie Pierre Castex, Anguella Ghanem, Brice Fresneau, Amandine Bertrand, Cecile Dumesnil, Cecile Faure Conter, Estelle Thebaud, Frédérique Dijoud, Angélique Rome
Publikováno v:
Journal of Pediatric Hematology/Oncology
Journal of Pediatric Hematology/Oncology, Lippincott, Williams & Wilkins, 2017, 39 (5), pp.388-394. ⟨10.1097/MPH.0000000000000823⟩
Journal of Pediatric Hematology/Oncology, Lippincott, Williams & Wilkins, 2017, 39 (5), pp.388-394. ⟨10.1097/MPH.0000000000000823⟩
Background Germ cell tumors with somatic malignant transformation (GCT with SMT) are rare in children and poorly described. Data are missing to determine if therapies should target the GCT, the SMT compound, or both simultaneously. Patients and metho
Autor:
Amir Ali Hamidieh, Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Seyed Asadollah Mousavi, Mahdi Jalili, Babak Bahar, Mona Kargar, Masoud Iravani, Mohammad Jahani, Arash Jalali
Publikováno v:
Journal of Pediatric Hematology/Oncology. 34:101-107
The most widely accepted conditioning regimen to allogeneic hematopoietic stem cell transplantation consists of total body irradiation, especially in patients affected by acute lymphoblastic leukemia (ALL). In this retrospective study, we report our
Autor:
Naoko Yasui, Satoshi Asanuma, Hideaki Sakata, Motohiro Kato, Katsuyoshi Koh, Nodoka Adachi, Ryoji Hanada
Publikováno v:
Journal of pediatric hematology/oncology. 36(4)
Cisplatin is an effective chemotherapeutic agent against pediatric cancers; however, ototoxicity is a concern. This study describes the frequency, severity, and clinical course of hearing loss in Japanese pediatric patients treated with cisplatin-bas
Autor:
Michela Casanova, Andrea Ferrari, Filippo Spreafico, Roberto Luksch, Monica Terenziani, Graziella Cefalo, Maura Massimino, Lorenza Gandola, Fabrizio Lombardi, Franca Fossati-Bellani
Publikováno v:
Journal of Pediatric Hematology/Oncology. 21:509-513
Few studies have addressed the influence of profound myelosuppressive therapy in contemporary protocols on infectious morbidity in pediatric oncology patients. This study evaluates the types of infections and the methods used to diagnose infection in
Autor:
Martin A. Walter, Noah Federman, Johannes Czernin, Theodore R. Hall, Martin Allen-Auerbach, Simone Dunkelmann, Franziska Walter
Publikováno v:
Journal of pediatric hematology/oncology. 34(2)
Many children with sarcomas undergo whole body 2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) and technetium methylene diphosphonate ((99)Tc-MDP) studies. It is unknown whether the combination of
Autor:
Gregg Hall, Abha A. Gupta, Ronnen Maze, Vicky Papaioannou, Michael Capra, Sheila Weitzman, David Dix
Publikováno v:
Journal of pediatric hematology/oncology. 28(2)
Cisplatin is an important chemotherapeutic agent in the treatment of many pediatric malignancies, but its use is limited in part by ototoxicity. The authors' institution has been administering standard-dose cisplatin by continuous infusion rather tha
Publikováno v:
Journal of pediatric hematology/oncology. 26(11)
Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease Objectives: To determine the clinical outcome and prognostic factors for overall survival in children with recurrent and/or primary ref